Logo

Inpharmatica Wins Japanese Pharma Customer for Predictive ADME Software

Oct 11, 2005

NEW YORK, Oct. 11 (GenomeWeb News) - Inpharmatica has licensed its Admensa Interactive predictive ADME software to Japanese pharmaceutical company Mochida, the company said today.

 

This is the second Japanese company that has licensed Admensa Interactive, and the sixth overall since Inpharmatica launched the product in February.

 

The agreement was secured in conjunction with PharmaDesign, Inpharmatica's sales and marketing partner in Japan, Inpharmatica said.

 

Financial details of the agreement were not disclosed.

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.